Literature DB >> 11950234

Pterygial derived fibroblasts express functionally active histamine and epidermal growth factor receptors.

Raj Maini1, David J Collison, Jill M Maidment, Peter D Davies, I Michael Wormstone.   

Abstract

Pterygia are characterised by a fleshy outgrowth of altered conjunctival tissue over the cornea and are most common in tropical regions. Pterygial fibroblasts are characteristically distinct from normal conjunctival fibroblasts, and therefore the aim of this study was to determine the presence and functional significance of histamine and epidermal growth factor (EGF) receptors in these cells. Pterygial specimens were cultured in vitro and cellular outgrowths were phenotypically characterised as fibroblasts using vimentin and cytokeratin staining. Intracellular calcium mobilization was used to characterise the functional activity of histamine receptors on these cells. Maximal response was obtained with 100 microM histamine. However, lower concentrations of histamine also caused mobilization of calcium that were totally abolished by pre-incubation with H1 but not H2 or H3 receptor antagonists. EGF receptor was diffusely expressed over the cell surfaces. EGF stimulated receptor internalization, ERK protein phosphorylation and intracellular calcium mobilization. Therefore, fibroblasts derived from human pterygia express functionally active histamine and epidermal growth factor receptors. Controlled modification of either the receptors or the appropriate ligands could have beneficial effects in pterygia treatment. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950234     DOI: 10.1006/exer.2001.1116

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium.

Authors:  Timothy M Nolan; Nick DiGirolamo; Nitin H Sachdev; Taline Hampartzoumian; Minas T Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation.

Authors:  Nick Di Girolamo; Minas Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Pterygium epithelium abnormal differentiation related to activation of extracellular signal-regulated kinase signaling pathway in vitro.

Authors:  Juan Peng; Xiang-Yin Sha; Yi Liu; Rui-Ming Yang; Ye Wen
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

4.  The involvement of adult stem cells originated from bone marrow in the pathogenesis of pterygia.

Authors:  Young Soo Song; Yang Hwan Ryu; Suk Rae Choi; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

5.  Immunohistochemical detection of Hsp90 and Ki-67 in pterygium.

Authors:  Roberto Sebastiá; Marcelo Palis Ventura; Helena Parente Solari; Emilia Antecka; Maria Eugenia Orellana; Miguel N Burnier
Journal:  Diagn Pathol       Date:  2013-02-21       Impact factor: 2.644

6.  Proliferative Effects of Histamine on Primary Human Pterygium Fibroblasts.

Authors:  Zhenwei Qin; Qiuli Fu; Lifang Zhang; Houfa Yin; Xiuming Jin; Qiaomei Tang; Danni Lyu; Ke Yao
Journal:  Mediators Inflamm       Date:  2016-10-30       Impact factor: 4.711

7.  Histamine activates an intracellular Ca2+ signal in normal human lung fibroblast WI-38 cells.

Authors:  Roberto Berra-Romani; Ajelet Vargaz-Guadarrama; Josué Sánchez-Gómez; Nayeli Coyotl-Santiago; Efraín Hernández-Arambide; José Everardo Avelino-Cruz; Mario García-Carrasco; Monica Savio; Giorgia Pellavio; Umberto Laforenza; Alfredo Lagunas-Martínez; Francesco Moccia
Journal:  Front Cell Dev Biol       Date:  2022-09-02

8.  Intraoperative ethanol treatment as an adjuvant therapy of pterygium excision.

Authors:  Ko-Hua Chen; Wen-Ming Hsu
Journal:  Int J Biomed Sci       Date:  2006-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.